Multivessel Disease

Improving HDL function may improve outcomes after acute MI for patients with multivessel disease and high LDL, according to a subanalysis of the AEGIS II trial presented at the National Lipid Association Scientific Sessions.

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

In patients aged 75 years or older with MI and multivessel CAD, physiology-guided complete revascularization improved outcomes compared with treating the culprit lesion only, according to the results of the FIRE trial.

In a real-world cohort of Medicare beneficiaries with ACS and multivessel CAD, CABG conferred lower odds of mortality, readmission and repeat procedures compared with PCI, researchers reported.

Outcomes after FFR-guided vs. angiography-guided strategy in treatment of non-infarction-related artery stenosis in acute MI with multivessel disease.

In patients with acute MI and multivessel CAD, a fractional flow reserve-guided PCI strategy for non-infarct-related artery lesions was superior to an angiography-guided PCI strategy, according to the results of the FRAME-AMI trial.

In a meta-analysis of trials of patients with STEMI and multivessel CAD who underwent PCI, those who had multivessel PCI had a lower rate of reinfarction than those who had culprit-vessel-only PCI.

In a retrospective study of patients with chronic total occlusion and multivessel CAD, CABG conferred better long-term outcomes than PCI, according to data presented at the virtual PCR e-Course.

Among patients with advanced established CAD, 18F-sodium fluoride PET may predict MI, according to data presented at the virtual American College of Cardiology Scientific Session.

In new findings from the TWILIGHT trial of patients who underwent PCI, switching from dual antiplatelet therapy to ticagrelor monotherapy after 3 months benefited patients who had complex PCI and patients with diabetes.